WTIM
BIIB icon

Wilmington Trust Investment Management’s Biogen BIIB Stock Holding History

Wilmington Trust Investment Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		$1.75M Sell
5,550
-300
-5% -$90.3K 0.36% 45
2014
Q1 		$1.79M Buy
5,850
+1,600
+38% +$508K 0.36% 51
2013
Q4 		$1.19M Sell
4,250
-200
-4% -$51.7K 0.24% 72
2013
Q3 		$1.07M Hold
4,450
– – 0.22% 77
2013
Q2 		$958K Buy
+4,450
New +$951K 0.21% 80

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Wilmington Trust Investment Management's BIIB Position: Q2 2014 in Review

Wilmington Trust Investment Management reduced its Biogen (BIIB) stake by 5.1% in Q2 2014, selling an estimated $90.3K and leaving 5,550 shares worth $1.75M. The position accounts for 0.36% of the portfolio, ranked #45.

Wilmington Trust Investment Management first reported a position in BIIB in Q2 2013 and has held it in 5 quarters since. The position peaked at $1.79M in Q1 2014. 782 funds tracked by Wall St. Rank hold BIIB as of Q2 2014.

  • Wilmington Trust Investment Management held 5,550 shares of Biogen worth $1.75M as of Q2 2014.
  • Wilmington Trust Investment Management sold 300 Biogen shares in Q2 2014, an estimated $90.3K.
  • Biogen made up 0.36% of Wilmington Trust Investment Management's portfolio in Q2 2014, its #45 holding.
  • Wilmington Trust Investment Management first reported a position in Biogen in Q2 2013 and has held it in 5 quarters since.
  • Wilmington Trust Investment Management's Biogen position peaked at $1.79M in Q1 2014.
  • 782 funds tracked by Wall St. Rank held Biogen as of Q2 2014.

Based on Wilmington Trust Investment Management's 13F filing for Q2 2014, filed 13 Aug 2014.